Here are the latest quarterly results of DIVIS LABORATORIES. For more details, see the DIVIS LABORATORIES financial fact sheet and DIVIS LABORATORIES share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Jun-22* |
3
Sep-22* |
3
Dec-22* |
3
Mar-23* |
3
Jun-23* |
3
Sep-23* |
3
Dec-23* |
3
Mar-24* |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | Rs m | 22,550 | 18,550 | 17,080 | 19,510 | 17,780 | 19,090 | 18,550 | 23,030 | |
Other income | Rs m | 880 | 800 | 1,130 | 660 | 810 | 860 | 950 | 790 | |
Turnover | Rs m | 23,430 | 19,350 | 18,210 | 20,170 | 18,590 | 19,950 | 19,500 | 23,820 | |
Expenses | Rs m | 14,070 | 12,340 | 12,990 | 14,640 | 12,740 | 14,300 | 13,660 | 15,720 | |
Gross profit | Rs m | 8,480 | 6,210 | 4,090 | 4,870 | 5,040 | 4,790 | 4,890 | 7,310 | |
Depreciation | Rs m | 840 | 860 | 870 | 870 | 930 | 950 | 950 | 950 | |
Interest | Rs m | 0 | 0 | 0 | 0 | 0 | 10 | 0 | 20 | |
Profit before tax | Rs m | 8,520 | 6,150 | 4,350 | 4,660 | 4,920 | 4,690 | 4,890 | 7,130 | |
Tax | Rs m | 1,500 | 1,220 | 1,290 | 1,450 | 1,360 | 1,210 | 1,310 | 1,750 | |
Profit after tax | Rs m | 7,020 | 4,930 | 3,060 | 3,210 | 3,560 | 3,480 | 3,580 | 5,380 | |
Gross profit margin | % | 37.6 | 33.5 | 23.9 | 25.0 | 28.3 | 25.1 | 26.4 | 31.7 | |
Effective tax rate | % | 17.6 | 19.8 | 29.7 | 31.1 | 27.6 | 25.8 | 26.8 | 24.5 | |
Net profit margin | % | 31.1 | 26.6 | 17.9 | 16.5 | 20.0 | 18.2 | 19.3 | 23.4 | |
Diluted EPS | Rs | 26.4 | 18.6 | 11.5 | 12.1 | 13.4 | 13.1 | 13.5 | 20.3 | |
Diluted EPS (TTM) | Rs | 117.0 | 112.7 | 90.2 | 68.6 | 55.6 | 50.1 | 52.1 | 60.3 | |
Subscriber Feature |
After opening the day marginally higher, Indian share turned negative as the session progressed and ended the day lower.